A Multicenter, Open-label Post Authorization Safety Study to Evaluate the Effect of LysaKare® Infusion on Serum Potassium Levels in GEP-NET Patients Eligible for Lutathera® Treatment

Description:

The purpose of the study is to evaluate the effect of arginine/lysine solution administration on serum potassium levels. A systematic assessment of serum potassium levels will be performed during infusion and up to 24 hours post start of infusion compared to baseline.

Sponsor:

Advanced Accelerator Applications

Contacts:

Novartis Pharmaceuticals

novartis.email@novartis.com

1-888-669-6682

Government Study Link:

NCT04524442 - Click here to see study on

ClinicalTrials.gov

Patient Education

Patient Education Not Yet Provided

Publications

Publications Not Yet Provided

Locations

Italy 🇮🇹

Istituto Europero di Oncologia

20141, Milano, Milan, Italy

Netherlands 🇳🇱

Erasmus University Medical Center

3015 CA, Rotterdam, South Holland, Netherlands

Poland 🇵🇱

Gammed-Centrum Diagnostyczno-Lecznicze

02-351, Warszawa, Masovian Voivodeship, Poland

United Kingdom 🇬🇧

Royal Surrey County Hospital

Guildford, Surrey, England, United Kingdom

Liverpool Royal Hospital

L7 8YA, Liverpool, Merseyside, England, United Kingdom

University Hospitals Coventry & Warwickshire NHS Trust

CV2 2DX, Coventry, West Midlands, England, United Kingdom

University Hospitals Birmingham NHS Foundation Trust

B15 2GW, Birmingham, West Midlands, England, United Kingdom

Contact XCancer: 402-991-8468